9.De Gottardi A.ThevenotT.SpahrL et al.Risk of complications after abdominal paracentesis in:a prospective study.Clin Gastroenterol Hepatol 2009:7:906. 10.Dabbagh O,Oza A.Prakash S.et al.Coaqulopathy does notprotect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest2010:137:1145 11.Tripodi A.Mannucci PM.The coagulopathy of chronicliver disease.N Engl J Med2011:365:147 12.Yeon JE.Kwon MJ,Hyung LJ,et al.Effect of fresh frozen plasma (FFP) transfusion on prothrombin time (PT)and bleeding control in patients with chronic liver disease.Hepatology 2010:52:908A. 13.Runvon BA.Canawati HN.Akriviadis EA.Optimization of ascitic fluid culture ech 9Y1988:95:1351 14.De Pietri L,Bianchini M,Montalti R,et al.Thrombelastography-quided blood product use before invasive procedures in cirrhosis with severe coaqulopathy: A randomized,controlled trial.Hepatology 2016:63:566. 15.Kim JJ,Tsukamoto MM,Mathur AK,et al.Delayed paracentesis is associated with incr eased in-hospital mo with spontaneous bacterial peritonitis Am J Gastroenterol 2014 109:14 16.Oelsner DH,Caldwell SH,Coles M,Driscoll CJ.Subumbilical midline vascularity of the abdominal wall in portal hypertension observed at laparoscopy.Gastrointest Endosc 1998:47:388. 17.Sakai H.Sheer TA.Mendler MH,Runyon BA.Choosing the location for non- image quided abdomina al paracen tesis.Liver Int2005:25:984 18.Runyon BA.Hoefs JC.Morgan TR.Asciticfluid analysis in malignancy-related ascites.Hepatology 1988:8:1104. 19.Runyon BA.Hoefs JC,Canawati HN.Polymicrobial bacterascites.A unique entity in the spectrum of infected ascitic fluid.Arch Intern Med 1986: 1462173 专题16203版本19.0.zh-Hans.1.09. De Gottardi A, Thévenot T, Spahr L, et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol 2009; 7:906. 10.Dabbagh O, Oza A, Prakash S, et al. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest 2010; 137:1145. 11.Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365:147. 12.Yeon JE, Kwon MJ, Hyung LJ, et al. Effect of fresh frozen plasma (FFP) transfusion on prothrombin time (PT) and bleeding control in patients with chronic liver disease. Hepatology 2010; 52:908A. 13.Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988; 95:1351. 14.De Pietri L, Bianchini M, Montalti R, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial. Hepatology 2016; 63:566. 15.Kim JJ, Tsukamoto MM, Mathur AK, et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol 2014; 109:1436. 16.Oelsner DH, Caldwell SH, Coles M, Driscoll CJ. Subumbilical midline vascularity of the abdominal wall in portal hypertension observed at laparoscopy. Gastrointest Endosc 1998; 47:388. 17.Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non - image guided abdominal paracentesis. Liver Int 2005; 25:984. 18.Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8:1104. 19.Runyon BA, Hoefs JC, Canawati HN. Polymicrobial bacterascites. A unique entity in the spectrum of infected ascitic fluid. Arch Intern Med 1986; 146:2173. 专题 16203 版本 19.0.zh-Hans.1.0